Suchergebnisse
Jacobs Stock Jumps 11.5% in a Month: Can This Rally Keep Running?
Shares of Jacobs Solutions Inc. J gained 11.5% over the past four weeks, drawing attention to whether the advance has more room to run.Record backlog, margin expansion and rising demand tied to
PacBio Q2 Earnings Meet Estimates, Revenues Miss, 2026 Sales View Cut
Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, reported an adjusted loss per share of 14 cents for the second quarter of 2026, wider than the year-ago adjusted loss of 13
Reservoir Media Highlights Growth, Catalog Deals as Board Reviews Buyout Proposals
Key Points
- Interested in Reservoir Media, Inc.? Here are five stocks we like better.
- Reservoir Media reported solid fiscal 2026 performance, with revenue rising 11%—including 6% organic
Goodyear Tire & Rubber Q2 Earnings Call Highlights
Key Points
- Interested in The Goodyear Tire & Rubber Company? Here are five stocks we like better.
- Goodyear’s second-quarter sales fell 5% to $4.3 billion, with tire volumes down 4% year over
Green Plains Q2 Earnings Call Highlights
Key Points
- Interested in Green Plains, Inc.? Here are five stocks we like better.
- Strong Q2 performance: Green Plains reported adjusted EBITDA of $93.3 million, net income of $67.1 million, and
Gladstone Commercial Q2 Earnings Call Highlights
Key Points
- Interested in Gladstone Commercial Corporation? Here are five stocks we like better.
- FFO increased: Second-quarter FFO and Core FFO each rose to $0.38 per share, up from $0.33 and
Gogo Q2 Earnings Call Highlights
Key Points
- Interested in Gogo Inc.? Here are five stocks we like better.
- Q2 revenue declined modestly to $222.8 million, while Gogo posted a $2 million net loss and adjusted EBITDA fell 13% year
Genmab A/S Q2 Earnings Call Highlights
Key Points
- Interested in Genmab A/S Sponsored ADR? Here are five stocks we like better.
- Genmab raised its 2026 outlook, now forecasting revenue of DKK 4.3 billion–DKK 4.5 billion and operating
GoodRx Q2 Earnings Call Highlights
Key Points
- Interested in GoodRx Holdings, Inc.? Here are five stocks we like better.
- GoodRx raised its full-year outlook after reporting Q2 revenue of $200.4 million and adjusted EBITDA of $63.7
Frontdoor Q2 Earnings Call Highlights
Key Points
- Interested in Frontdoor Inc.? Here are five stocks we like better.
- Frontdoor delivered solid Q2 growth: Revenue rose 5% to $645 million, adjusted EBITDA increased 10% to $220
FOX Q4 Earnings Call Highlights
Key Points
- Interested in Fox Corporation? Here are five stocks we like better.
- FOX reported record fiscal 2026 performance, with revenue up 5% to more than $17 billion and EBITDA up 8% to $3.9
Fluence Energy Q3 Earnings Call Highlights
Key Points
- Interested in Fluence Energy, Inc.? Here are five stocks we like better.
- Record demand: Fluence signed $1.44 billion in fiscal Q3 orders, up nearly threefold year over year, while
LTM Q2 Earnings Beat on Strong Passenger and Cargo Revenues
LATAM Airlines Group S.A. (LTM) reported second-quarter 2026 earnings of 58 cents per share, which beat the Zacks Consensus Estimate of 14 cents by 314.3%. The bottom line declined 28.4% year over
3 Stocks to Watch After Crushing Q2 Earnings Expectations: CAT, MCY & ZBRA
The second-quarter earnings season has produced several standout performers. That said, the biggest winners haven't simply topped Wall Street's estimates—they've delivered blowout results while
Block's Q2 Earnings & Revenues Beat on Cash App & Square Strength
Block, Inc. XYZ reported second-quarter 2026 adjusted earnings per share (EPS) of $1.02, up 64.5% year over year and above the Zacks Consensus Estimate of 86 cents by 18.6%.
Revenues rose 9.3% to
Is Landstar Stock a Buy After Its Strong Earnings and Revenue Rebound?
Landstar System, Inc. LSTR has a stronger near-term investment case after its second-quarter rebound in revenues, earnings and freight pricing. The stock’s Zacks Rank #1 (Strong Buy), favorable
ANGO's FY27 Guidance Puts Med Tech Growth and Tariff Risks in Focus
AngioDynamics, Inc. ANGO has set an initial fiscal 2027 framework that keeps its Med Tech transformation at the center of the investment case. Faster growth from its priority platforms is expected
ANGO Jumps 33.5% in 3 Months: Can the Rally Keep Going?
AngioDynamics, Inc. ANGO shares have gained 33.5% in the past three months, sharply outpacing the broader market and the medical sector. The rally reflects growing interest in the company’s shift
Insmed Q2 Earnings Call Highlights
Key Points
- Interested in Insmed, Inc.? Here are five stocks we like better.
- BRINSUPRI sales accelerated: Second-quarter revenue reached $309.2 million, up 49% sequentially, prompting Insmed to
Immunovant Q1 Earnings Call Highlights
Key Points
- Interested in Immunovant, Inc.? Here are five stocks we like better.
- FDA decision and potential launch: Roivant expects an FDA decision by the end of September on brepocitinib for